Position in MRNA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$3,151
+$865 QoQ
Shares Held
45
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#696
of 777 holders
Holding Since
Dec 2020
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blume Capital Management, Inc. holds $67,999 across 8 Biotechnology names. MRNA ranks #4 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABCL |
AbCellera Biologics Inc.
|
4,484 | $35,199 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
2,300 | $20,136 | |
| 3 | EXEL |
Exelixis, Inc.
|
115 | $6,257 | |
| 4 | MRNA |
Moderna, Inc.
This page
|
45 | $3,151 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
50 | $2,727 | |
| 6 | MNKD |
Mannkind Corp
|
100 | $426 | |
| 7 | INO |
Inovio Pharmaceuticals, Inc.
|
83 | $91 | |
| 8 | LXRX |
Lexicon Pharmaceuticals, Inc.
|
5 | $12 |
All Filings in MRNA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,151 | 45 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $2,286 | 45 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,327 | 45 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,162 | 45 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,241 | 45 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,389 | 49 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,871 | 45 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,007 | 45 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $5,343 | 45 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,795 | 45 | Shares | Sole | 2024-05-02 | |
| 2020-12-31 | $208 | 2 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||